- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Commercial Services
- Sub-Industry: Research&Development
WuXi PharmaTech Cayman Inc
+ Add to Watchlist3W11:GR
15.953 EUR 0.219 1.39%As of 02:38:10 ET on 05/23/2013.
Snapshot for WuXi PharmaTech Cayman Inc (3W11)
| Open: | 16.105 | Day's Range: | 15.953 - 16.105 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 15.734 | 52wk Range: | 9.378 - 16.426 | 1-Yr Rtn: | +43.66% |
Key Statistics for 3W11
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 13.4762 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 1.5310 |
| Est. PEG Ratio | 1.0951 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 69 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 3W11
Company Profile & Key Executives for 3W11
WuXi PharmaTech Cayman, Inc. provides pharmaceutical and biotechnology research and development outsourcing. The Company's services include discovery chemistry, service biology, analytical, pharmaceutical development, and manufacturing.
| Ge LiChairman/CEO/Co-Founder | Edward Hu "Ed"CFO/COO |
| Shuhui ChenChief Scientific Officer | Suhan TangChief Manufacturing Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
3W11 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page